P2-223 Perfusoin weighted magnetic resonance imaging (PW-MRI) in Alzheimer's disease (ad) and mild cognitive impairment (MCI): initial experience
2012 ◽
Vol 40
(2)
◽
pp. 717-725
◽
2017 ◽
Vol 60
(3)
◽
pp. 877-887
◽
2020 ◽
Vol 90
◽
pp. 84-92
◽
2015 ◽
Vol 49
(6)
◽
pp. 349-353
◽
2001 ◽
Vol 71
(4)
◽
pp. 441-447
◽